antiviral drug remdesivir
At day 11, around 76% of the patients in the 5-day treatment group showed improvement in clinical status versus 66% for standard care alone, Gilead said.
June 1, 2020
Remdesivir is being studied in multiple ongoing international clinical trials, and the safety and efficacy of remdesivir for the treatment of Covid-19 are not yet established.
May 6, 2020